Del. Justices Back Axing Suit Over $3B AstraZeneca Viela Sale

The Delaware Supreme Court on Wednesday upheld without elaboration the dismissal of a Court of Chancery lawsuit accusing AstraZeneca PLC of lining up a conflicted, underpriced $3 billion sale of clinical...

Already a subscriber? Click here to view full article